I N Todor

I N Todor

Auto-generated profile, based on publicly available information

I N Todor

R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv 03022, Ukraine

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2012
Verified
Journal Article
Closed access
ITI N Todor
I N Todor
NLN Yu Lukyanova
N Yu Lukyanova
VCV F Chekhun
V F Chekhun

22 March 2015 in Experimental Oncology
Verified
Journal Article
Closed access
ITI N Todor
I N Todor
NLN Yu Lukianova
N Yu Lukianova
YSYu V Shvets
Yu V Shvets
YLYu V Lozovska
Yu V Lozovska
VCV F Chekhun
V F Chekhun
Aim: To study indices of energy metabolism, content of K+ and Mg++ both in peripheral blood and in Walker-256 carcinosarcoma during development of resistance to doxorubicin. Methods: Resistance of Walker-256 carcinosarcoma to doxorubicin has been developed through 12 subsequent transplantations of tumor after the chemotherapy. Parental strain was inhibited by drug by 65%, while transitional resistant substrains — by 30% and 2%, respectively. Determination of biochemical indices in blood serum and homogenates of tumor tissue, level of potassium, magnesium, lactate, glucose, activities of lactate dehydrogenase and glucose6-phosphate dehydrogenase was performed with the help of biochemical and immune-enzyme analyzer GBG ChemWell 2990 (USA) using standard kits. Polarography was used to determine indices of mitochondrial oxidative phosphorylation. Study of mitochondrial membrane potential was carried out on flow cytometer Beckman Coulter Epics XL using dye JC-1. Results: It has been determined that development of drug resistance causes the decrease of K+, Mg++, glucose content in blood serum and increase of these indices in tumor tissue. At the same time, gradual tumor’s loss of sensitivity is characterized by decrease of glycolysis activity in it and activation of mitochondrial oxidative phosphorylation and pentose phosphate pathway of glucose degradation, which causes more intensive formation of NADPH. Conclusion: Development of drug resistance of tumor causes certain metabolic changes in organism and tumor. Further study of such changes will make possible to determine tumor and extratumor markers of resistance.

1 January 2012
Verified
Journal Article
Closed access
LRLiudmyla Rieznichenko
Liudmyla Rieznichenko
SDSvitlana Dybkova
Svitlana Dybkova
TGTamara Gruzina
Tamara Gruzina
ZUZ R Ulberg
Z R Ulberg
ITI N Todor
I N Todor
VCV F Chekhun
V F Chekhun

1 December 2010
Verified
Journal Article
Closed access
OYO V Yurchenko
O V Yurchenko
ITI N Todor
I N Todor
IKI K Khayetsky
I K Khayetsky
NTN A Tregubova
N A Tregubova
NLN Yu Lukianova
N Yu Lukianova
VCV F Chekhun
V F Chekhun

1 March 2010
Verified
Journal Article
Closed access
MNM M Nosko
M M Nosko
VPV M Pivnyuk
V M Pivnyuk
GSG I Solyanik
G I Solyanik
GKG I Kulik
G I Kulik
ITI N Todor
I N Todor
VCV F Chekhun
V F Chekhun

1 September 2014
Verified
Journal Article
Closed access
VCV F Chekhun
V F Chekhun
YLY V Lozovska
Y V Lozovska
ABA P Burlaka
A P Burlaka
NLN Y Lukyanova
N Y Lukyanova
ITI N Todor
I N Todor
LNL A Naleskina
L A Naleskina